Naseem Amin
CIK 1646754 · last filed 2026-02-12
Naseem Amin is a corporate insider who has filed 19 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider disposed of $462.0K of AVDL on Feb 12, 2026. Across all open-market trades the lifetime net is +$400.0K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
19
$400.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Director | 0 | $21.64 | $0 | $0 | 4 | 2026-02-12 |
| Bellerophon Therapeutics, Inc. (BLPH) Delisted | Director | 291,865 | $0.01 | $3.5K | $400.0K | 15 | 2023-06-09 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-12 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Disp (D) | −22,000 | -$462.0K | EDGAR |
| 2025-07-31 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +11,000 | $0 | EDGAR |
| 2024-08-01 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +11,000 | $0 | EDGAR |
| 2024-05-21 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Grant (A) | +47,578 | $0 | EDGAR |
| 2023-02-14 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Grant (A) | +84,000 | $0 | EDGAR |
| 2022-01-04 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Grant (A) | +39,032 | $0 | EDGAR |
| 2020-09-14 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-30 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-25 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Buy (P) | +571,429 | $400.0K | EDGAR |